QI
HSTO

QS Investors’s Histogen Inc. Common Stock HSTO Stock Holding History

QS Investors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-484
Closed -$105K – 1697
2019
Q1 		$105K Hold
484
– – ﹤0.01% 1390
2018
Q4 		$168K Hold
484
– – ﹤0.01% 1184
2018
Q3 		$561K Hold
484
– – 0.01% 934
2018
Q2 		$414K Hold
484
– – ﹤0.01% 992
2018
Q1 		$568K Hold
484
– – 0.01% 909
2017
Q4 		$447K Buy
484
+3
+0.6% +$2.77K ﹤0.01% 966
2017
Q3 		$528K Buy
+481
New +$547K ﹤0.01% 947

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

QS Investors's HSTO Position: Q2 2019 in Review

QS Investors sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 484 shares — an estimated $105K sold.

QS Investors first reported a position in HSTO in Q3 2017 and held it in 7 quarters. The position peaked at $568K in Q1 2018. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • QS Investors reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • QS Investors sold 484 Histogen Inc. Common Stock shares in Q2 2019, an estimated $105K.
  • QS Investors first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • QS Investors's Histogen Inc. Common Stock position peaked at $568K in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on QS Investors's 13F filing for Q2 2019, filed 14 Aug 2019.